OpenAlex
PricingAboutJobs
Log inGet started
Work

CLINICAL STUDY: Predicting the effect of naltrexone and acamprosate in alcohol‐dependent patients using genetic indicators

HTML

Year: 2009
Type: article
Study design: Clinical Trial
Source: Addiction Biology
DOI: 10.1111/j.1369-1600.2009.00159.x
Authors: Wendy Ooteman, Mickaël Naassila, Maarten W. J. Koeter, Roel Verheul, Gerard M. Schippers, Hakim Houchi, Martine Daoust, Wim Van Den Brink
Institutions: San Francisco VA Medical Center, University of California, San Francisco, Amsterdam UMC Location University of Amsterdam, Amsterdam Institute for Addiction Research, University of Amsterdam, Inserm, Groupe de Recherche sur l'Alcool et les Pharmacodépendances, Université de Picardie Jules Verne, De Viersprong
Language: English

Topic: Substance Abuse Treatment and Outcomes
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Keywords: naltrexone, acamprosate, alcoholism, pharmacogenomics, patient-treatment matching, cue-induced craving, cue reactivity, DRD2 polymorphism, GABRA6, GABRB2, OPRM1, dopamine receptors, opioid receptors, alcoholism treatment
SDG: Good health and well-being

Open Access status: closed

Funder: Nederlandse Organisatie voor Wetenschappelijk Onderzoek
OpenAlex ID: W1585479090
FWCI: 5.886
Cites: 28
Cited by: 88
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security